Published • loading... • Updated
What to know about psychedelic retreats, a booming business with few safety guardrails
Nearly 90% of surveyed retreats require or recommend stopping certain medications, while experts warn there are no industrywide safety standards.
- Hundreds of retreats across the globe offer psychedelic-assisted experiences, yet the industry currently operates with virtually no oversight or standard safety regulations.
- On Saturday, President Donald Trump signed an executive order directing the Food and Drug Administration to accelerate reviews of psychedelics showing potential for treating PTSD.
- Nearly 90% of surveyed retreats require attendees to stop taking medications like Prozac, a practice medical experts warn carries significant risks without professional supervision.
- Biomedical ethicist Amy McGuire of Baylor College notes that operators may mandate these breaks to maximize the experience for paying customers, creating a 'business rationale' for potentially dangerous practices.
- Joshua White of the Fireside Project warns of a potential 'race to the bottom' regarding accountability, urging prospective attendees to rigorously research facilitators and safety protocols.
Insights by Ground AI
15 Articles
15 Articles
What to know about psychedelic retreats, a booming business with few safety guardrails - The Boston Globe
Hundreds of outfits across the world are offering multiday trips where attendees pay for drug-assisted experiences claiming to promote psychological healing, personal growth, and other benefits.
·Boston, United States
Read Full ArticleCoverage Details
Total News Sources15
Leaning Left9Leaning Right0Center4Last UpdatedBias Distribution69% Left
Bias Distribution
- 69% of the sources lean Left
69% Left
L 69%
C 31%
Factuality
To view factuality data please Upgrade to Premium










